ERICA MULLEN: Open Payments
NPI 1194282103 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$316 in 16 payments from 8 companies in 2025. Trend: 2023 $107 · 2024 $305 · 2025 $316
Food & beverage: $316
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $66 |
| Abbott Laboratories | 3 | $65 |
| Otsuka America Pharmaceutical, Inc. | 2 | $58 |
| ABBVIE INC. | 3 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| PFIZER INC. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: MOUNJARO, FREESTYLE LIBRE 3, REXULTI, VRAYLAR, AIRSUPRA, ELIQUIS, TRELEGY ELLIPTA, XIFAXAN.
Industry payments across MO — which companies pay providers there.
